慢性乙型肝炎基层诊疗指南(实践版·2020)

2021-03-25 中华医学会 中华全科医师杂志.2021.20(3):281-289.

慢性乙型肝炎病毒(hepatitis B virus,HBV)感染:指乙型肝炎表面抗原(HBsAg)和/或HBV 脱氧核糖核酸(HBV DNA)阳性6个月以上。

中文标题:

慢性乙型肝炎基层诊疗指南(实践版·2020)

发布机构:

中华医学会

发布日期:

2021-03-25

简要介绍:

慢性乙型肝炎病毒(hepatitis B virus,HBV)感染:指乙型肝炎表面抗原(HBsAg)和/或HBV 脱氧核糖核酸(HBV DNA)阳性6个月以上。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=慢性乙型肝炎基层诊疗指南(实践版·2020).pdf)] GetToolGuiderByIdResponse(projectId=1, id=e3a5d1c002083357, title=慢性乙型肝炎基层诊疗指南(实践版·2020), enTitle=, guiderFrom=中华全科医师杂志.2021.20(3):281-289., authorId=0, author=, summary=慢性乙型肝炎病毒(hepatitis B virus,HBV)感染:指乙型肝炎表面抗原(HBsAg)和/或HBV 脱氧核糖核酸(HBV DNA)阳性6个月以上。, cover=https://img.medsci.cn/2021420/1618929298663_2020535.jpg, journalId=0, articlesId=null, associationId=359, associationName=中华医学会, associationIntro=中华医学会是中国医学科学技术工作者自愿组成并依法登记成立的学术性、公益性、非营利性法人社团,是党和国家联系医学科技工作者的桥梁和纽带,是发展中国医学科学技术事业的重要社会力量。 中华医学会(Chinese Medical Association)成立于1915年。现有83个专科分会,50万名会员,下设部门16个,法人实体机构3个,另与解放军军事医学科学院合办医学图书馆1个。 中华医学会的主要业务包括:开展医学学术交流;编辑出版123种医学、科普等各类期刊及100余种音像出版物;开展继续医学教育;开展国际间学术交流;开展医学科技项目的评价、评审和医学科学技术决策论证;评选和奖励优秀医学科技成果(包括学术论文和科普作品等);开展专科医师的培训和考核;发现、推荐和培养优秀医学科技人才;宣传、奖励医德高尚、业务精良的医务人员;承担政府委托职能及承办委托任务;设立临床研究专项资金,提高临床科研水平;组织医疗事故技术鉴定和预防接种异常反应技术鉴定工作;推动医学科研成果的转化和应用;向党和政府反映医学科技工作者的意见和要求。, copyright=0, guiderPublishedTime=Thu Mar 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>慢性乙型肝炎病毒(hepatitis B virus,HBV)感染:指乙型肝炎表面抗原(HBsAg)和/或HBV 脱氧核糖核酸(HBV DNA)阳性6个月以上。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=2629, tagName=慢性乙型肝炎)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2629, guiderKeyword=慢性乙型肝炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=30529, appHits=436, showAppHits=0, pcHits=1264, showPcHits=30090, likes=4, shares=43, comments=53, approvalStatus=1, publishedTime=Tue Apr 20 23:14:38 CST 2021, publishedTimeString=2021-03-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue Apr 20 22:35:06 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 20:11:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=慢性乙型肝炎基层诊疗指南(实践版·2020).pdf)])
慢性乙型肝炎基层诊疗指南(实践版·2020).pdf
下载请点击:
评论区 (40)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200590, encodeId=3371120059003, content=指导性强,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:08:09 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200552, encodeId=0966120055262, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 14:24:57 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200055, encodeId=6d3f120005572, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd655079620, createdName=145add1bm97暂无昵称, createdTime=Sun Mar 06 22:09:20 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190175, encodeId=385711901e561, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Fri Feb 04 18:52:09 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080069, encodeId=32d61080069e2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ab52554163, createdName=1254af2bm28暂无昵称, createdTime=Tue Dec 14 21:01:20 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2022-03-08 gghhzb

    指导性强,值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200590, encodeId=3371120059003, content=指导性强,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:08:09 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200552, encodeId=0966120055262, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 14:24:57 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200055, encodeId=6d3f120005572, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd655079620, createdName=145add1bm97暂无昵称, createdTime=Sun Mar 06 22:09:20 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190175, encodeId=385711901e561, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Fri Feb 04 18:52:09 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080069, encodeId=32d61080069e2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ab52554163, createdName=1254af2bm28暂无昵称, createdTime=Tue Dec 14 21:01:20 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2022-03-08 gghhzb

    很实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200590, encodeId=3371120059003, content=指导性强,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:08:09 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200552, encodeId=0966120055262, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 14:24:57 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200055, encodeId=6d3f120005572, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd655079620, createdName=145add1bm97暂无昵称, createdTime=Sun Mar 06 22:09:20 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190175, encodeId=385711901e561, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Fri Feb 04 18:52:09 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080069, encodeId=32d61080069e2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ab52554163, createdName=1254af2bm28暂无昵称, createdTime=Tue Dec 14 21:01:20 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2022-03-06 145add1bm97暂无昵称

    很实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1200590, encodeId=3371120059003, content=指导性强,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:08:09 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200552, encodeId=0966120055262, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 14:24:57 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200055, encodeId=6d3f120005572, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd655079620, createdName=145add1bm97暂无昵称, createdTime=Sun Mar 06 22:09:20 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190175, encodeId=385711901e561, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Fri Feb 04 18:52:09 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080069, encodeId=32d61080069e2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ab52554163, createdName=1254af2bm28暂无昵称, createdTime=Tue Dec 14 21:01:20 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2022-02-04 xiexuejian

    很实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1200590, encodeId=3371120059003, content=指导性强,值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 16:08:09 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200552, encodeId=0966120055262, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d852717242, createdName=gghhzb, createdTime=Tue Mar 08 14:24:57 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200055, encodeId=6d3f120005572, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd655079620, createdName=145add1bm97暂无昵称, createdTime=Sun Mar 06 22:09:20 CST 2022, time=2022-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190175, encodeId=385711901e561, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf9f5004226, createdName=xiexuejian, createdTime=Fri Feb 04 18:52:09 CST 2022, time=2022-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080069, encodeId=32d61080069e2, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7ab52554163, createdName=1254af2bm28暂无昵称, createdTime=Tue Dec 14 21:01:20 CST 2021, time=2021-12-14, status=1, ipAttribution=)]
    2021-12-14 1254af2bm28暂无昵称

    谢谢

    0

拓展阅读

美国慢性乙型肝炎感染的治疗规范:2015年更新版

美国肝病研究学会(AASLD,American Association for the Study of Liver Diseases) · 2016-06-02

2015 中国慢性乙型肝炎防治指南—— 特殊人群抗病毒治疗推荐意见解读

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2015-03-11

2015 中国慢性乙型肝炎防治指南解读

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2016-03-10

聚乙二醇干扰素α治疗慢性乙型肝炎专家共识

中国肝病科相关专家小组(统称) · 2017-09-30